Skip to main content

Brett Sandercock

Equibles does not estimate personal net worth.

About Brett Sandercock

Brett Sandercock was last confirmed as Board Member at Resmed Inc (RMD) in a filing dated October 2, 2025. Earlier roles on record: CFO at Resmed Inc (RMD) until May 4, 2026. Resmed Inc reported in an 8-K filed April 30, 2026 that Brett Sandercock retired as Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer, effective May 4, 2026. The proxy statement of Resmed Inc reports total compensation of $3,768,003 for Brett Sandercock in fiscal 2026, including a base salary of $600,164. Disclosed compensation is on record for 5 fiscal years. Brett Sandercock has spoken on 25 earnings calls across 1 company, most recently for Resmed Inc on April 30, 2026. The companies whose calls Brett Sandercock spoke on are classified in the Healthcare sector.

“On April 30, 2026, ResMed Inc. (the "Company") announced that Brett Sandercock, Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer, will retire from his role as Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer.”
Resmed Inc Form 8-K, filed April 30, 2026 · Read the filing

Brett Sandercock on recent calls

“In my remarks today, I will provide an overview of our results for the third quarter fiscal year 2026 unless noted all comparisons out of the prior year quarter and in constant currency terms were applicable.”
CFO, Resmed Inc Q3 FY2026 Earnings Call ·
“Sorry about the call dropped out, but I'm back now. I'm ready to go, Mick. All right, great. Thank you, Mick. In my remarks today, I'll provide an overview of our results for the second quarter of fiscal year 2026.”
CFO, Resmed Inc Q2 FY2026 Earnings Call ·
“In my remarks today, I will provide an overview of our results for the first quarter of fiscal year 2026. Unless noted, all comparisons are to the prior year quarter and in constant currency terms, where applicable.”
CFO, Resmed Inc Q1 FY2026 Earnings Call ·
“In my remarks today, I will provide an overview of our results for the third quarter of fiscal 2025. Unless noted, all comparisons are to the prior year quarter and in constant currency terms where applicable.”
CFO, Resmed Inc Q3 FY2025 Earnings Call ·
“In my remarks today, I'll provide an overview of our results for the second quarter of fiscal year 2025. Unless noted, all comparisons under the prior year quarter and in constant currency terms were applicable.”
CFO, Resmed Inc Q2 FY2025 Earnings Call ·

Affiliation history

  • Resmed Inc (RMD)

    Board Member

    Proxy statement

    Start not stated–2025-10-02

    Last confirmed by a filing; no departure on record

  • Resmed Inc (RMD)

    CFO

    Source not stated

    Start not stated–2026-05-04

Company network

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2026 Resmed Inc (RMD) $600,164 $3,768,003
2025 Resmed Inc (RMD) $498,967 $3,572,010
2024 Resmed Inc (RMD) $471,039 $3,233,565
2023 Resmed Inc (RMD) $467,002 $3,109,690
2022 Resmed Inc (RMD) $472,225 $2,891,331

Recent activity

Show 14 earlier activities